'Caution needed' on hospital visits for patients with blood-borne viruses during pandemic

ASHM taskforce offers advice on keeping at-risk patients safe

Initiation of direct-acting antivirals (DAAs) for hepatitis C can be deferred in people with pre-cirrhosis stages of liver disease if services are stretched during the COVID-19 pandemic, new guidance suggests.

But it’s important patients who have cirrhosis try to keep to their schedule of surveillance ultrasounds.

ASHM (the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine) has released a set of documents to help clinicians manage adults living with blood-borne viruses and